Inflammation Can Be a High-Risk Factor for Mucosal Nonunion of MRONJ by Regulating SIRT1 Signaling When Treated with an Oncologic Dose of Zoledronate

References

• Nicolatou-Galitis O, Kouri M, Papadopoulou E, et al. Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Support Care Canc. 2019;27(2):383–394. doi:10.1007/s00520-018-4501-x
   PubMed Web of Science ®Google Scholar
• Ruggiero SL, Dodson TB, Aghaloo T, Carlson ER, Ward BB, Kademani D. American association of oral and maxillofacial surgeons’ position paper on medication-related osteonecrosis of the jaws-2022 update. J Oral Maxillof Surg. 2022;80(5):920–943. doi:10.1016/j.joms.2022.02.008
   PubMed Web of Science ®Google Scholar
• Yamashita J, McCauley LK. Antiresorptives and osteonecrosis of the jaw. J Evid Based Dent Pract. 2012;12(3 Suppl):233–247. doi:10.1016/S1532-3382(12)70046-5
   PubMedGoogle Scholar
• Reid IR, Bolland MJ, Grey AB. Is bisphosphonate-associated osteonecrosis of the jaw caused by soft tissue toxicity? Bone. 2007;41(3):318–320. doi:10.1016/j.bone.2007.04.196
   PubMed Web of Science ®Google Scholar
• Kyrgidis A, Vahtsevanos K, Koloutsos G, et al. Bisphosphonate-related osteonecrosis of the jaws: a case-control study of risk factors in breast cancer patients. J Clin Oncol. 2008;26(28):4634–4638. doi:10.1200/JCO.2008.16.2768
   PubMed Web of Science ®Google Scholar
• Hoff AO, Toth BB, Altundag K, et al. Frequency and risk factors associated with osteonecrosis of the jaw in cancer patients treated with intravenous bisphosphonates. J Bone Mineral Res. 2008;23(6):826–836. doi:10.1359/jbmr.080205
   PubMed Web of Science ®Google Scholar
• Zandi M, Dehghan A, Janbaz P, Malekzadeh H, Amini P. The starting point for bisphosphonate-related osteonecrosis of the jaw: alveolar bone or oral mucosa? A randomized, controlled experimental study. J Craniomaxillofac Surg. 2017;45(1):157–161. doi:10.1016/j.jcms.2016.10.015
   PubMed Web of Science ®Google Scholar
• Voss PJ, Stoddart M, Ziebart T, et al. Zoledronate induces osteonecrosis of the jaw in sheep. J Craniomaxillofac Surg. 2015;43(7):1133–1138. doi:10.1016/j.jcms.2015.04.020
   PubMed Web of Science ®Google Scholar
• Bullock G, Miller C, McKechnie A, Hearnden V. Synthetic hydroxyapatite inhibits bisphosphonate toxicity to the oral mucosa in vitro. Materials. 2020;13(9):2086. doi:10.3390/ma13092086
   PubMed Web of Science ®Google Scholar
• Hoff AO, Toth B, Hu M, Hortobagyi GN, Gagel RF. Epidemiology and risk factors for osteonecrosis of the jaw in cancer patients. Ann N Y Acad Sci. 2011;1218:47–54. doi:10.1111/j.1749-6632.2010.05771.x
   PubMed Web of Science ®Google Scholar
• Black DM, Delmas PD, Eastell R, et al. Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis. New Engl J Med. 2007;356(18):1809–1822. doi:10.1056/NEJMoa067312
   PubMed Web of Science ®Google Scholar
• Skerjanec A, Berenson J, Hsu C, et al. The pharmacokinetics and pharmacodynamics of zoledronic acid in cancer patients with varying degrees of renal function. J Clin Pharmacol. 2003;43(2):154–162. doi:10.1177/0091270002239824
   PubMed Web of Science ®Google Scholar
• Shiraki M, Tanaka S, Suzuki H, Ueda S, Nakamura T. Safety, pharmacokinetics, and changes in bone metabolism associated with zoledronic acid treatment in Japanese patients with primary osteoporosis. J Bone Mineral Metabol. 2017;35(6):675–684. doi:10.1007/s00774-016-0806-3
   PubMed Web of Science ®Google Scholar
• Weiss HM, Pfaar U, Schweitzer A, Wiegand H, Skerjanec A, Schran H. Biodistribution and plasma protein binding of zoledronic acid. Drug Metabol Disposit. 2008;36(10):2043–2049. doi:10.1124/dmd.108.021071
   PubMed Web of Science ®Google Scholar
• Troeltzsch M, Zeiter S, Arens D, et al. Chronic periodontal infection and not iatrogenic interference is the trigger of medication-related osteonecrosis of the jaw: insights from a large animal study (PerioBRONJ Pig Model). Medicina. 2023;59(5). doi:10.3390/medicina59051000
   PubMedGoogle Scholar
• Soundia A, Hadaya D, Esfandi N, et al. Zoledronate impairs socket healing after extraction of teeth with experimental periodontitis. J Dent Res. 2018;97(3):312–320. doi:10.1177/0022034517732770
   PubMed Web of Science ®Google Scholar
• Elsubeihi ES, Heersche JN. Quantitative assessment of post-extraction healing and alveolar ridge remodelling of the mandible in female rats. Arch Oral Biol. 2004;49(5):401–412. doi:10.1016/j.archoralbio.2003.12.003
   PubMed Web of Science ®Google Scholar
• Calenic B, Greabu M, Caruntu C, Tanase C, Battino M. Oral keratinocyte stem/progenitor cells: specific markers, molecular signaling pathways and potential uses. Periodontol. 2015;69(1):68–82. doi:10.1111/prd.12097
   Google Scholar
• Ko KI, Sculean A, Graves DT. Diabetic wound healing in soft and hard oral tissues. Transl Res. 2021;236:72–86. doi:10.1016/j.trsl.2021.05.001
   PubMed Web of Science ®Google Scholar
• Amler MH. The time sequence of tissue regeneration in human extraction wounds. Oral Surg Oral Med Oral Pathol. 1969;27(3):309–318. doi:10.1016/0030-4220(69)90357-0
   PubMedGoogle Scholar
• Guo S, Dipietro LA. Factors affecting wound healing. J Dent Res. 2010;89(3):219–229. doi:10.1177/0022034509359125
   PubMed Web of Science ®Google Scholar
• Koçer G, Nazıroğlu M, Çelik Ö, et al. Basic fibroblast growth factor attenuates bisphosphonate-induced oxidative injury but decreases zinc and copper levels in oral epithelium of rat. Biol Trace Elem Res. 2013;153(1–3):251–256. doi:10.1007/s12011-013-9659-y
   PubMed Web of Science ®Google Scholar
• Awodele O, Olayemi SO, Nwite JA, Adeyemo TA. Investigation of the levels of oxidative stress parameters in HIV and HIV-TB co-infected patients. J Infect Dev Ctries. 2012;6(1):79–85. doi:10.3855/jidc.1906
   PubMed Web of Science ®Google Scholar
• Lebreton F, van Schaik W, Sanguinetti M, et al. AsrR is an oxidative stress sensing regulator modulating Enterococcus faecium opportunistic traits, antimicrobial resistance, and pathogenicity. PLoS Pathog. 2012;8(8):e1002834. doi:10.1371/journal.ppat.1002834
   PubMed Web of Science ®Google Scholar
• Bagan J, Sáez GT, Tormos MC, et al. Oxidative stress in bisphosphonate-related osteonecrosis of the jaws. J Oral Pathol Med. 2014;43(5):371–377. doi:10.1111/jop.12151
   PubMed Web of Science ®Google Scholar
• Tamaoka J, Takaoka K, Hattori H, et al. Osteonecrosis of the jaws caused by bisphosphonate treatment and oxidative stress in mice. Exp Ther Med. 2019;17(2):1440–1448. doi:10.3892/etm.2018.7076
   PubMed Web of Science ®Google Scholar
• Taniguchi N, Osaki M, Onuma K, et al. Bisphosphonate-induced reactive oxygen species inhibit proliferation and migration of oral fibroblasts: a pathogenesis of bisphosphonate-related osteonecrosis of the jaw. J Periodontol. 2020;91(7):947–955. doi:10.1002/JPER.19-0385
   PubMed Web of Science ®Google Scholar
• Dan Dunn J, Alvarez LA, Zhang X, Soldati T. Reactive oxygen species and mitochondria: a nexus of cellular homeostasis. Redox Biol. 2015;6:472–485. doi:10.1016/j.redox.2015.09.005
   PubMed Web of Science ®Google Scholar
• Zorov DB, Juhaszova M, Sollott SJ. Mitochondrial reactive oxygen species (ROS) and ROS-induced ROS release. Physiol Rev. 2014;94(3):909–950. doi:10.1152/physrev.00026.2013
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang W, Yang P, Zhu S, Luo S, Li M. Menaquinone-4 prevents medication-related osteonecrosis of the jaw through the SIRT1 signaling-mediated inhibition of cellular metabolic stresses-induced osteoblast apoptosis. Free Radic Biol Med. 2023;206:33–49. doi:10.1016/j.freeradbiomed.2023.06.022
   PubMed Web of Science ®Google Scholar
• Davizon-Castillo P, McMahon B, Aguila S, et al. TNF-α-driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of aging. Blood. 2019;134(9):727–740. doi:10.1182/blood.2019000200
   PubMed Web of Science ®Google Scholar
• Waldman M, Cohen K, Yadin D, et al. Regulation of diabetic cardiomyopathy by caloric restriction is mediated by intracellular signaling pathways involving ‘SIRT1 and PGC-1α’. Cardiovasc Diabetol. 2018;17(1):111. doi:10.1186/s12933-018-0754-4
   PubMedGoogle Scholar
• Singh CK, Chhabra G, Ndiaye MA, Garcia-Peterson LM, Mack NJ, Ahmad N. The role of sirtuins in antioxidant and redox signaling. Antioxid Redox Signal. 2018;28(8):643–661. doi:10.1089/ars.2017.7290
   PubMed Web of Science ®Google Scholar
• Vega RB, Horton JL, Kelly DP. Maintaining ancient organelles: mitochondrial biogenesis and maturation. Circ Res. 2015;116(11):1820–1834. doi:10.1161/CIRCRESAHA.116.305420
   PubMed Web of Science ®Google Scholar
• Iwabu M, Yamauchi T, Okada-Iwabu M, et al. Adiponectin and AdipoR1 regulate PGC-1alpha and mitochondria by Ca(2+) and AMPK/SIRT1. Nature. 2010;464(7293):1313–1319. doi:10.1038/nature08991
   PubMed Web of Science ®Google Scholar
• Xu Q, Zhan P, Li X, et al. Bisphosphonate-enoxacin inhibit osteoclast formation and function by abrogating RANKL-induced JNK signalling pathways during osteoporosis treatment. J Cell & Mol Med. 2021;25(21):10126–10139. doi:10.1111/jcmm.16949
   PubMed Web of Science ®Google Scholar
• Jiang Y, Yang P, Li C, et al. Periostin regulates LPS-induced apoptosis via Nrf2/HO-1 pathway in periodontal ligament fibroblasts. Oral Dis. 2023;29(5):2188–2204. doi:10.1111/odi.14189
   PubMed Web of Science ®Google Scholar
• Qu B, Gong K, Yang H, et al. SIRT1 suppresses high glucose and palmitate-induced osteoclast differentiation via deacetylating p66Shc. Molec Cellul Endocrinol. 2018;474:97–104. doi:10.1016/j.mce.2018.02.015
   PubMed Web of Science ®Google Scholar
• Aguirre JI, Castillo EJ, Kimmel DB. Preclinical models of medication-related osteonecrosis of the jaw (MRONJ). Bone. 2021;153:116184. doi:10.1016/j.bone.2021.116184
   PubMed Web of Science ®Google Scholar
• Zhao N, Li QX, Wang YF, et al. Anti-angiogenic drug aggravates the degree of anti-resorptive drug-based medication-related osteonecrosis of the jaw by impairing the proliferation and migration function of gingival fibroblasts. BMC Oral Health. 2023;23(1):330. doi:10.1186/s12903-023-03034-7
   PubMed Web of Science ®Google Scholar
• Nicolatou-Galitis O, Schiødt M, Mendes RA, et al. Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;127(2):117–135. doi:10.1016/j.oooo.2018.09.008
   PubMed Web of Science ®Google Scholar
• Chang J, Hakam AE, McCauley LK. Current understanding of the pathophysiology of osteonecrosis of the Jaw. Curr Osteoporos Rep. 2018;16(5):584–595. doi:10.1007/s11914-018-0474-4
   PubMed Web of Science ®Google Scholar
• Hujiahemaiti M, Sun X, Zhou J, et al. Effects of quercetin on human oral keratinocytes during re-epithelialization: an in vitro study. Arch Oral Biol. 2018;95:187–194. doi:10.1016/j.archoralbio.2018.08.004
   PubMed Web of Science ®Google Scholar
• Pabst AM, Ziebart T, Koch FP, Taylor KY, Al-Nawas B, Walter C. The influence of bisphosphonates on viability, migration, and apoptosis of human oral keratinocytes--in vitro study. Clin Oral Investigat. 2012;16(1):87–93. doi:10.1007/s00784-010-0507-6
   PubMed Web of Science ®Google Scholar
• Limones A, Sáez-Alcaide LM, Díaz-Parreño SA, Helm A, Bornstein MM, Molinero-Mourelle P. Medication-related osteonecrosis of the jaws (MRONJ) in cancer patients treated with denosumab VS. zoledronic acid: a systematic review and meta-analysis. Med Oral Patol Oral Cir Bucal. 2020;25(3):e326–e336. doi:10.4317/medoral.23324
   PubMed Web of Science ®Google Scholar
• Park KM, Cheong J, Pang NS, Kim KD, Lee JS, Park W. Medication-related osteonecrosis of the jaw using periodontitis-induced rat before tooth extraction. BMC Oral Health. 2023;23(1):561. doi:10.1186/s12903-023-03200-x
   PubMed Web of Science ®Google Scholar
• Tamari T, Elimelech R, Cohen G, et al. Endothelial Progenitor Cells inhibit jaw osteonecrosis in a rat model: a major adverse effect of bisphosphonate therapy. Sci Rep. 2019;9(1):18896. doi:10.1038/s41598-019-55383-5
   PubMedGoogle Scholar
• Kozutsumi R, Kuroshima S, Kaneko H, Sasaki M, Ishisaki A, Sawase T. Zoledronic acid deteriorates soft and hard tissue healing of murine tooth extraction sockets in a dose-dependent manner. Calcif Tissue Internat. 2022;110(1):104–116. doi:10.1007/s00223-021-00890-9
   PubMed Web of Science ®Google Scholar
• Vahtsevanos K, Kyrgidis A, Verrou E, et al. Longitudinal cohort study of risk factors in cancer patients of bisphosphonate-related osteonecrosis of the jaw. J Clin Oncol. 2009;27(32):5356–5362. doi:10.1200/JCO.2009.21.9584
   PubMed Web of Science ®Google Scholar
• Bilezikian JP. Osteonecrosis of the jaw--do bisphosphonates pose a risk? New Engl J Med. 2006;355(22):2278–2281. doi:10.1056/NEJMp068157
   PubMed Web of Science ®Google Scholar
• Thumbigere-Math V, Michalowicz BS, Hodges JS, et al. Periodontal disease as a risk factor for bisphosphonate-related osteonecrosis of the jaw. J Periodontol. 2014;85(2):226–233. doi:10.1902/jop.2013.130017
   PubMed Web of Science ®Google Scholar
• Soutome S, Otsuru M, Hayashida S, et al. Relationship between tooth extraction and development of medication-related osteonecrosis of the jaw in cancer patients. Sci Rep. 2021;11(1):17226. doi:10.1038/s41598-021-96480-8
   PubMed Web of Science ®Google Scholar
• Kara M, Boran T, Öztaş E, Jannuzzi AT, Özden S, Özhan G. Zoledronic acid-induced oxidative damage and endoplasmic reticulum stress-mediated apoptosis in human embryonic kidney (HEK-293) cells. J Biochem Mol Toxicol. 2022;36(8):e23083. doi:10.1002/jbt.23083
   PubMed Web of Science ®Google Scholar
• Bryan N, Ahswin H, Smart N, Bayon Y, Wohlert S, Hunt JA. Reactive oxygen species (ROS)--A family of fate deciding molecules pivotal in constructive inflammation and wound healing. Eur Cell Mater. 2012;24:249–265. doi:10.22203/eCM.v024a18
   PubMed Web of Science ®Google Scholar
• Mohammed AI, Sangha S, Nguyen H, et al. Assessment of Oxidative Stress-Induced Oral Epithelial Toxicity. Biomolecules. 2023;13(8):1239. doi:10.3390/biom13081239
   PubMed Web of Science ®Google Scholar
• Pierfelice TV, Lazarevic M, Mitic D, et al. Red light and 5% aminolaevulinic Acid (5%) inhibit proliferation and migration of dysplastic oral keratinocytes via ROS production: an in vitro study. Gels. 2023;9(8):604. doi:10.3390/gels9080604
   PubMed Web of Science ®Google Scholar
• Rizwan H, Pal S, Sabnam S, Pal A. High glucose augments ROS generation regulates mitochondrial dysfunction and apoptosis via stress signalling cascades in keratinocytes. Life Sci. 2020;241:117148. doi:10.1016/j.lfs.2019.117148
   PubMed Web of Science ®Google Scholar
• Raghu G, Berk M, Campochiaro PA, et al. The Multifaceted Therapeutic Role of N-Acetylcysteine (NAC) in Disorders Characterized by Oxidative Stress. Curr Neuropharmacol. 2021;19(8):1202–1224. doi:10.2174/1570159X19666201230144109
   PubMed Web of Science ®Google Scholar
• Peoples JN, Saraf A, Ghazal N, Pham TT, Kwong JQ. Mitochondrial dysfunction and oxidative stress in heart disease. Exp Mol Med. 2019;51(12):1–13. doi:10.1038/s12276-019-0355-7
   PubMed Web of Science ®Google Scholar
• Yang Y, Liu Y, Wang Y, et al. Regulation of SIRT1 and Its Roles in Inflammation. Front Immunol. 2022;13:831168. doi:10.3389/fimmu.2022.831168
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhang J, Zheng Y, et al. NAD(+) improves cognitive function and reduces neuroinflammation by ameliorating mitochondrial damage and decreasing ROS production in chronic cerebral hypoperfusion models through Sirt1/PGC-1α pathway. J Neuroinflammation. 2021;18(1):207. doi:10.1186/s12974-021-02250-8
   PubMed Web of Science ®Google Scholar
• Christovam AC, Theodoro V, Mendonça FAS, Esquisatto MAM, Dos Santos GMT, Do Amaral MEC. Activators of SIRT1 in wound repair: an animal model study. Archives of Dermatological Res. 2019;311(3):193–201. doi:10.1007/s00403-019-01901-4
   PubMed Web of Science ®Google Scholar
• Ungvari Z, Bagi Z, Feher A, et al. Resveratrol confers endothelial protection via activation of the antioxidant transcription factor Nrf2. Am J Phys Heart Circulat Physiol. 2010;299(1):H18–24. doi:10.1152/ajpheart.00260.2010
   PubMed Web of Science ®Google Scholar
• Chen ML, Yi L, Jin X, et al. Resveratrol attenuates vascular endothelial inflammation by inducing autophagy through the cAMP signaling pathway. Autophagy. 2013;9(12):2033–2045. doi:10.4161/auto.26336
   PubMed Web of Science ®Google Scholar
• Chen Y, Zhang H, Ji S, et al. Resveratrol and its derivative pterostilbene attenuate oxidative stress-induced intestinal injury by improving mitochondrial redox homeostasis and function via SIRT1 signaling. Free Radic Biol Med. 2021;177:1–14. doi:10.1016/j.freeradbiomed.2021.10.011
   PubMed Web of Science ®Google Scholar
• Lee JH, Kim JS, Park SY, Lee YJ. Resveratrol induces human keratinocyte damage via the activation of class III histone deacetylase, Sirt1. Oncol Rep. 2016;35(1):524–529. doi:10.3892/or.2015.4332
   PubMed Web of Science ®Google Scholar
• Gokce EH, Tuncay Tanrıverdi S, Eroglu I, et al. Wound healing effects of collagen-laminin dermal matrix impregnated with resveratrol loaded hyaluronic acid-DPPC microparticles in diabetic rats. Europ J Pharmaceut Biopharmac. 2017;119:17–27. doi:10.1016/j.ejpb.2017.04.027
   PubMed Web of Science ®Google Scholar
• Eroğlu İ, Gökçe EH, Tsapis N, et al. Evaluation of characteristics and in vitro antioxidant properties of RSV loaded hyaluronic acid-DPPC microparticles as a wound healing system. Colloids Surf B. 2015;126:50–57. doi:10.1016/j.colsurfb.2014.12.006
   PubMed Web of Science ®Google Scholar
• Kaleci B, Koyuturk M. Efficacy of resveratrol in the wound healing process by reducing oxidative stress and promoting fibroblast cell proliferation and migration. Dermatologic Therapy. 2020;33(6):e14357. doi:10.1111/dth.14357
   PubMed Web of Science ®Google Scholar
• Goodman SB, Maruyama M. Inflammation, bone healing and osteonecrosis: from bedside to bench. J Inflamm Res. 2020;13:913–923. doi:10.2147/JIR.S281941
   PubMed Web of Science ®Google Scholar
• Wu RQ, Zhang DF, Tu E, Chen QM, Chen W. The mucosal immune system in the oral cavity-An orchestra of T cell diversity. Int J Oral Sci. 2014;6(3):125–132. doi:10.1038/ijos.2014.48
   PubMed Web of Science ®Google Scholar
• Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21(7):426–440. doi:10.1038/s41577-020-00488-6
   PubMed Web of Science ®Google Scholar
• Meyle J, Chapple I. Molecular aspects of the pathogenesis of periodontitis. Periodontology. 2015;69(1):7–17. doi:10.1111/prd.12104
   Google Scholar
• Gaudet C, Odet S, Meyer C, et al. Reporting criteria for clinical trials on medication-related osteonecrosis of the Jaw (MRONJ): a review and recommendations. Cells. 2022;11(24):4097. doi:10.3390/cells11244097
   PubMed Web of Science ®Google Scholar